Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.080
+0.030 (2.86%)
At close: Jun 26, 2026, 4:00 PM EDT
1.040
-0.040 (-3.70%)
After-hours: Jun 26, 2026, 7:44 PM EDT
Tempest Therapeutics Employees
Tempest Therapeutics had 5 employees as of March 31, 2026. The number of employees increased by 1 or 25.00% since the number was last reported on December 31, 2025.
Employees
5
Change
1
Growth
25.00%
Revenue / Employee
n/a
Profits / Employee
-$8,619,600
Market Cap
15.99M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Quince Therapeutics | 38 |
| Lunai Bioworks | 29 |
| Citius Pharmaceuticals | 23 |
| Moleculin Biotech | 17 |
| Atossa Therapeutics | 16 |
| Werewolf Therapeutics | 14 |
| Exicure | 2 |
| GT Biopharma | 1 |
TPST News
- 16 hours ago - Tempest Therapeutics registers to sell 2.43M shares of common stock for holders - TheFly
- 1 day ago - Tempest Therapeutics Registration statement: Registration filing - Filings
- 19 days ago - Tempest Therapeutics Proxy statement: Proxy filing - Filings
- 22 days ago - Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors - GlobeNewsWire
- 4 weeks ago - Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds - GlobeNewsWire
- 4 weeks ago - Tempest Therapeutics Proxy statement: Proxy filing - Filings
- 6 weeks ago - Tempest Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Tempest Therapeutics Earnings release: Q1 2026 - Filings